When recombinant lubricin was injected in injured joints, in a study on animal model of OA, its improved chondroprotection, suggesting its potential use in new approaches for the treatment of OA and other cartilage disease [44,45,46,47,48]. The gene discussed is PRG4; the disease is cartilage disease.